Natural Progression of Left Ventricular Function following Anthracyclines without Cardioprotective Therapy: A Systematic Review and Meta-Analysis.

Ainsley Ryan Yan Bin LeeChun En YauChen Ee LowJiaqi LiSara Moiz TyeballyWeiqin LinLi-Ling TanChia-Te LiaoWei-Ting ChangMatilda Xinwei LeeChieh Yang Koo Ching-Hui Sia

Published in: Cancers (2023)

While the mean LVEF decline in patients without cardioprotective therapy was clinically small, a vulnerable subset experienced significant impairment. Further research to best identify those who benefit most from cardioprotective therapies when receiving anthracyclines is required.

Keyphrases

left ventricular
end stage renal disease
chronic kidney disease
newly diagnosed
heart failure
prognostic factors
peritoneal dialysis
acute myocardial infarction
mitral valve
hypertrophic cardiomyopathy
atrial fibrillation
acute coronary syndrome
left atrial